Clinical associations and potential cellular mechanisms linking G6PD deficiency and atherosclerotic cardiovascular disease
Abstract Glucose 6-phosphate dehydrogenase deficiency (G6PD-d) is the most common enzymopathy in the world, occurring in 5–8% of the global population (half a billion people). Recent epidemiological evidence suggests that G6PD-d may be associated with increased cardiovascular disease (CVD). Atherosc...
Saved in:
| Main Authors: | Patrick H. Andrews, James C. Zimring, Coleen A. McNamara |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | npj Metabolic Health and Disease |
| Online Access: | https://doi.org/10.1038/s44324-025-00061-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Late-Life Presentation of Unsuspected G6PD Deficiency
by: Marcos Benchimol, et al.
Published: (2018-01-01) -
Use of nimotuzumab in the patient with G-6-PD deficiency: The first world report
by: Viroj Wiwanitkit
Published: (2013-01-01) -
The Impact of G6PD Deficiency on Liver Function in Children Under 15
by: Saad Mahmood Saeed, et al.
Published: (2024-02-01) -
G6PD deficiency triggers dopamine loss and the initiation of Parkinson’s disease pathogenesis
by: Morgan G. Stykel, et al.
Published: (2025-01-01) -
ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND ORAL HEALTH: PATHOPHYSIOLOGICAL LINKS AND CLINICAL IMPLICATIONS
by: Luiza Camelia Nechita, et al.
Published: (2025-03-01)